(Q54438048)

English

[Clinical experience with imipenem/cilastatin in the treatment of severe infections in general surgery].

scientific article published in January 1986

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3079549

[Clinical experience with imipenem/cilastatin in the treatment of severe infections in general surgery]. (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3079549

imipenem/cilastatin

1 reference

based on heuristic

inferred from title

author name string

M Mayer

1

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3079549

J Brand

2

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3079549

D Schlenkhoff

3

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3079549

W Opferkuch

4

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3079549

language of work or name

0 references

publication date

1 January 1986

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3079549

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3079549

14 Suppl 2

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3079549

S160-3

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3079549

In vitro activity of N-formimidoyl thienamycin (MK0787) against resistant strains of Pseudomonas aeruginosa, Staphylococcus epidermidis, Serratia marcescens, and Enterococcus spp

1 reference

https://api.crossref.org/works/10.1007%2FBF01647502

21 January 2018

Antibacterial activity of N-formimidoyl-thienamycin in comparison with other beta-lactam antibiotics against clinical problem strains (author's transl)

1 reference

https://pubmed.ncbi.nlm.nih.gov/3079549

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Simple screening method for gram-positive bacterial beta-lactam antibiotic tolerance on routine laboratory Bauer-Kirby antibiogram plates.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3079549

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

beta-Lactamase activity of renal dipeptidase against N-formimidoyl-thienamycin

1 reference

https://pubmed.ncbi.nlm.nih.gov/3079549

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of the antibacterial activities of N-formimidoyl thienamycin (MK0787) with those of other recently developed beta-lactam derivatives

1 reference

https://pubmed.ncbi.nlm.nih.gov/3079549

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibacterial activity of N-formimidoyl thienamycin in comparison with cefotaxime, lamoxactam, cefoperazone, piperacillin gentamicin

1 reference

https://pubmed.ncbi.nlm.nih.gov/3079549

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Hospital infections and problems of resistance today]

1 reference

https://pubmed.ncbi.nlm.nih.gov/3079549

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activity of N-formimidoyl thienamycin, moxalactam, and other new beta-lactam agents against Bacteroides fragilis: contribution of beta-lactamase to resistance

1 reference

https://pubmed.ncbi.nlm.nih.gov/3079549

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of imipenem/cilastatin therapy on normal fecal flora.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3079549

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of skin and soft tissue infections with imipenem/cilastatin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3079549

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urinary recovery of N-formimidoyl thienamycin (MK0787) as affected by coadministration of N-formimidoyl thienamycin dehydropeptidase inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/3079549

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibiotic-resistant staphylococci in a teaching hospital.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3079549

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The in vitro activity of N-formimidoyl thienamycin compared with other broad-spectrum cephalosporins and with clindamycin and metronidazole.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3079549

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Open trial of imipenem/cilastatin therapy for serious bacterial infections.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3079549

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF01647502

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3079549

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3079549

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54438048&oldid=2212467079"